Project Grant R43GM145102
- The National Science Foundation (NSF) awarded a $513,894 Project Grant under its Mathematical and Physical Sciences program (CFDA 47.049) to Tufts University. This 3-year grant, effective July 1, 2023, supports Professor Clay S. Bennett's research to develop new methods for synthesizing deoxy sugars - an important component of many biologically active natural products. The project aims to expand upon approaches that activate sugar hemiacetals as glycosyl sulfonates or tert-butyldimethylsilyl...
- This $575,000 project grant awarded by the National Science Foundation's (NSF) Division of Chemistry (CFDA 47.049 - Mathematical and Physical Sciences) will support a research effort led by Professor George O'Doherty at Northeastern University to develop novel synthetic methods for the asymmetric synthesis of oligosaccharide structures. The project aims to enable the efficient, de novo construction of both natural and unnatural oligosaccharide motifs, which have important applications in biology...
- Federal Grant Award Summary The National Science Foundation (NSF) Division of Chemistry awarded Tufts University $586,353 under the Mathematical and Physical Sciences program (CFDA 47.049) to develop synthetic methods for deoxy sugar oligosaccharide glycopeptides—a class of molecules with potent biological activity and unprecedented chemical structures. Under the direction of Dr. Clay S. Bennett, the project, which runs from August 1, 2026, through July 31, 2029, will advance the first total...
- Project Grant Award Summary The National Science Foundation's Division of Chemistry awarded $650,000 to the University of Oklahoma to support research on sulfur-mediated strategies for stereocontrolled glycosylation under the Mathematical and Physical Sciences program (CFDA 47.049). Beginning August 1, 2026, and concluding July 31, 2029, Dr. Indrajeet Sharma will develop sustainable synthetic chemistry methods for producing carbohydrate-based molecules critical to pharmaceuticals, vaccines,...
- This $249,000 Project Grant, awarded on September 1, 2025, through the National Institute of General Medical Sciences' Biomedical Research and Research Training program (CFDA 93.859), supports the development of chemoenzymatic synthesis approaches utilizing enzyme library screening to enable the preparation of biologically active molecules. The research focuses on leveraging biocatalysts—enzymes derived from bacterial and fungal sources—to facilitate the synthesis of polyhydroxylated...
- This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) award provides $274,727 to Weka Biosciences LLC, a woman-owned small business, to develop a novel microbial process for creating a synthetic sugar polymer for use in chiral chromatography. The goal is to produce a more reliable and efficient polymer material to enhance the precision of drug manufacturing and contribute to safer, more effective medications. The 12-month project will focus on...
- This $249,000 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) supports fundamental research to expand the catalytic capabilities of enzymes beyond their natural functions. Awarded to Duke University's Office of Research Administration on September 1, 2025, with completion targeted for August 31, 2028, the project focuses on engineering heme enzymes and methionine sulfoxide reductases to...
- Professor Liming Zhang of the University of California, Santa Barbara will develop new methods for the automated synthesis of glycans under a three-year, $575,000 Project Grant from the National Science Foundation Division of Chemistry. The grant falls under the NSF's Mathematical and Physical Sciences program (CFDA 47.049). Specifically, Professor Zhang will further develop and validate the Directing-Group-on-Leaving-Group strategy for stereoselective glycosylation reactions appropriate for...
- This $369,651 project grant awarded by the National Science Foundation's (NSF) Engineering program (CFDA 47.041) supports research at Ferris State University to characterize the biosynthesis of glycosylated anthracyclines, a class of polyketide natural products with potential anti-cancer and antibiotic properties. The project aims to refactor two higher anthracycline pathways in actinomycetes and use combinatorial biosynthesis to synthesize new anthracycline analogs with potentially novel...
- This Project Grant award from the National Science Foundation (NSF) under the Biological Sciences program (CFDA 47.074) provides $369,297 to San Francisco State University (SFSU) to develop a synthetic transhydrogenation module to enhance the production of valuable chemicals using engineered organisms. The key objectives are to: Elucidate the structural mechanisms underlying the autoregulation of the GltAB-GudB enzyme complex in Bacillus subtilis, which regulates glutamate metabolism and impacts...
PRODUCTION OF NATURAL DEOXYSUGARS FOR CHEMICAL SYNTHESIS OF GLYCOSIDES - PROJECT SUMMARY THE ULTIMATE GOAL OF THE PROPOSAL PRESENTED HEREIN IS TO PRODUCE NATURALLY OCCURRING 6-DEOXYSUGARS, INCLUDING DI- AND TRI-DEOXYSUGARS, AMINO SUGARS AND BRANCHED-CHAIN SUGARS. THESE SPECIALIZED HEXOSES ARE FOUND AS IMPORTANT STRUCTURAL COMPONENTS THROUGHOUT PLANT AND MICROBIAL SECONDARY METABOLITES, OFTEN PLAYING A CRUCIAL ROLE IN CONFERRING ACTIVITY IN BIOACTIVE NATURAL PRODUCTS, SUCH AS ANTIBIOTICS AND ANTICANCER THERAPEUTICS. THEY ARE OF INCREASING INTEREST IN GLYCOENGINEERING EFFORTS, WHICH AIM TO ALTER SUGAR SUBSTITUENTS FOUND ON GLYCOSYLATED NATURAL PRODUCTS OR APPEND SUGAR MOIETIES TO NON-GLYCOSYLATED NATURAL PRODUCTS. IN NATURE, 6-DEOXYSUGARS ARE FREQUENTLY BUILT UP AND MODIFIED AS PART OF ACTIVATED DTDP-NUCLEOSIDE SUGARS INSTEAD OF INDEPENDENT MOLECULES. WE PROPOSE TO INVESTIGATE A NOVEL APPROACH TO PRODUCE THESE RARE DEOXYSUGARS USING A PROPRIETARY E. COLI SYSTEM WE FIRST DEVELOPED TO PRODUCE ACTIVATED TDP-DEOXYSUGARS. TO DO THIS, THERE ARE A NUMBER OF CHALLENGES WHICH NEED TO BE OVERCOME. FIRST, TITERS OF THE TDP-DEOXYSUGARS NEED TO BE INCREASED, PREFERENTIALLY ACCUMULATING MORE MATERIAL IN THE GROWTH MEDIUM. SECOND, AN EFFECTIVE WAY TO SEPARATE AND PURIFY THE MOLECULES FROM THE GROWTH MEDIUM NEEDS TO BE DEVELOPED. FINALLY, THE DEOXYSUGARS NEED TO BE HYDROLYZED AND ISOLATED. SPECIFICALLY, IN PHASE I WE WILL DEMONSTRATE THE FEASIBILITY OF DEOXYSUGAR PRODUCTION USING D-FUCOSE DERIVED FROM DTDP-D-FUCOSE AS A MODEL. THIS WILL BE ACCOMPLISHED BY 1) INCREASING PRODUCTION OF DTDP-D- FUCOSE BY ENHANCING EXPRESSION AND SOLUBILITY OF FCF1, THE ENZYME USED TO MAKE DTDP-D-FUCOSE FROM TKDG, 2) DETERMINING A CHEMICALLY DEFINED MEDIUM CAPABLE OF PRODUCING LARGER QUANTITIES OF DTDP-D-FUCOSE IN THE MEDIUM, 3) DEVELOPING A DTDP-D-FUCOSE PURIFICATION PROTOCOL FROM THE CHEMICALLY DEFINED MEDIUM, 4) DEVELOPING A METHOD FOR HYDROLYSIS OF DTDP-D-FUCOSE AND THE SUBSEQUENT PURIFICATION OF D-FUCOSE. IN PHASE II, WE WILL EXPAND THE PROCESS TO MANUFACTURE AT LEAST 18 ADDITIONAL DEOXYSUGARS FROM DTDP- DEOXYSUGARS. OPTIMIZATION OF THE DTDP-DEOXYSUGAR PRODUCTION PATHWAYS WILL BE CONDUCTED TO INCREASE THE AMOUNT IN THE MEDIUM TO AT LEAST 500 MG/L. THIS WILL ALLOW US TO PRODUCE UP TO A GRAM OF EACH DEOXYSUGAR FROM A SINGLE 10 L FERMENTER. IN PHASE III, WE WILL COMMERCIALIZE THE DEOXYSUGARS, INDIVIDUALLY AND AS A KIT, TO RESEARCHERS IN ACADEMIA AND INDUSTRY. THROUGH EXPANDED PRODUCTION, THE WORK DONE IN PHASES I AND II WILL ALSO HELP SUPPORT THE SALE OF OUR DTDP-ACTIVATED DEOXYSUGARS.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 9/28/23 | ||
| Not listed | $0 | 9/19/22 | ||
| Not listed | $0 | 9/19/22 | ||
| Not listed | $0 | 9/19/22 | ||
| Not listed | $0 | 8/30/22 |